Citation Impact
Citing Papers
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
2004 StandoutScience
Reassessment of inflammation of airways in chronic bronchitis.
1985
Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial
2009 Standout
Idiopathic Pulmonary Fibrosis: Current Concepts
1998
Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring.
1997
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome.
1991
Determinants of progression in idiopathic pulmonary fibrosis.
1994
Small-Vessel Vasculitis
1997 Standout
Association of Malignancy With Diseases Causing Interstitial Pulmonary Changes
2002
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
2009
Pathophysiology of airflow limitation in chronic obstructive pulmonary disease
2004
Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease
1991
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
2014 Standout
The Acute Respiratory Distress Syndrome
2000 Standout
Cardiac Stem Cells and Mechanisms of Myocardial Regeneration
2005
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
Wound repair and regeneration
2008 StandoutNature
Structural Features of Interstitial Lung Disease in Systemic Sclerosis
1991
Evaluation of a Ventilation Strategy to Prevent Barotrauma in Patients at High Risk for Acute Respiratory Distress Syndrome
1998 Standout
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
2004 Standout
Sarcoidosis: social predictors of severity at presentation
2004
One-Year Outcomes in Survivors of the Acute Respiratory Distress Syndrome
2003 Standout
Tissue Destruction by Neutrophils
1989 Standout
Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part II)
1994
Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome.
1994
A Preliminary Study of Long-Term Treatment with Interferon Gamma-1b and Low-Dose Prednisolone in Patients with Idiopathic Pulmonary Fibrosis
1999
Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.
1994
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
1992 StandoutNature
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
2011 Standout
Scleroderma
2009 Standout
Cyclophosphamide pulse therapy in idiopathic pulmonary fibrosis
1998
Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2.
1995
Interstitial Lung Disease in Systemic Sclerosis
2008 Standout
Cyclophosphamide in the Treatment of Idiopathic Pulmonary Fibrosis
2000
Clinical Exercise Testing
2001
Effect of a Protective-Ventilation Strategy on Mortality in the Acute Respiratory Distress Syndrome
1998 Standout
Aerosolized Surfactant in Adults with Sepsis-Induced Acute Respiratory Distress Syndrome
1996
The Diagnosis, Assessment and Treatment of Diffuse Parenchymal Lung Disease in Adults
1999
Acute respiratory distress syndrome
2019 Standout
The Use, Abuse, and Mystique of Positive End-Expiratory Pressure
1988
Lung Fibrosis is Ameliorated by Pirfenidone Fed in Diet After the Second Dose In A Three-Dose Bleomycin-Hamster Model
1998
Surfactant and the Adult Respiratory Distress Syndrome
1993
Stem cells, ageing and the quest for immortality
2006 StandoutNature
Functional Disability 5 Years after Acute Respiratory Distress Syndrome
2011 Standout
Use of Intermittent, Intravenous Cyclophosphamide for Idiopathic Pulmonary Fibrosis
1992
Marked Goblet Cell Hyperplasia with Mucus Accumulation in the Airways of Patients Who Died of Severe Acute Asthma Attack
1992
Virus-induced autoantibody response to a transgenic viral antigen
1990 StandoutNatureNobel
Corticosteroids and the Treatment of Idiopathic Pulmonary Fibrosis
1996
Ventilator-Induced Lung Injury
2013 Standout
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Idiopathic Pulmonary Fibrosis
2001 Standout
Sarcoidosis
1997 Standout
The Fas Death Factor
1995 StandoutScience
Clinical deterioration in patients with idiopathic pulmonary fibrosis: Causes and assessment
1990
Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial
2009 Standout
Airway Mucus Function and Dysfunction
2010 Standout
Immunoglobulin G and Its Function in the Human Respiratory Tract
1988
Determinants of survival in idiopathic pulmonary fibrosis.
1994
Idiopathic Pulmonary Fibrosis: Abnormalities in the Bronchoalveolar Lavage Content of Surfactant Protein A
1991
Functional impairment in fibrosing alveolitis: relationship to reversible disease on thin section computed tomography
1997
Recent advances in the immunology of interstitial lung disease
1991
Idiopathic pulmonary fibrosis
2011 Standout
Clinical Determinants of Abnormalities in Pulmonary Functions in Survivors of the Adult Respiratory Distress Syndrome
1989
Diagnostic Advances in Idiopathic Pulmonary Fibrosis
1991
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
Sarcoidosis
2007 Standout
Autoimmunity and Apoptosis
2001 StandoutNobel
Surfactant protein A predicts survival in idiopathic pulmonary fibrosis.
1995
Incidence and Outcomes of Acute Lung Injury
2005 Standout
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts
1998
Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta.
1994
SARS-CoV-2 vaccines in development
2020 StandoutNature
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
2005
Predicting Survival in Idiopathic Pulmonary Fibrosis
2001
Nonspecific Interstitial Pneumonia
1998
Changes in Clinical and Physiologic Variables Predict Survival in Idiopathic Pulmonary Fibrosis
2003
Idiopathic Pulmonary Fibrosis
1998
Idiopathic Pulmonary Fibrosis
1998 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Long-Term Physiologic Consequences of the Adult Respiratory Distress Syndrome.
1977
Rapidly fatal pulmonary fibrosis: the accelerated variant of interstitial pneumonitis.
1979
Idiopathic Pulmonary Fibrosis
2000
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
2019 Standout
Immune Complexes, Gallium Lung Scans, and Bronchoalveolar Lavage in Idiopathic Interstitial Pneumonitis-Fibrosis
1983
Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival
1980
Bronchial Lavage in Inflammatory Lung Disease
1983
Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.
1989
Prognosis of cryptogenic fibrosing alveolitis.
1983
Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.
1987
Higher versus Lower Positive End-Expiratory Pressures in Patients with the Acute Respiratory Distress Syndrome
2004 Standout
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
2001 Standout
Comparison of conventional and high-frequency ventilation: oxygenation and lung pathology
1983
Non-steroid agents for idiopathic pulmonary fibrosis
2010
Prognostic Role of Eosinophils in Pulmonary Fibrosis
1987
Reactive Airways Dysfunction Syndrome (RADS)
1985 Standout
Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils
1997 StandoutNobel
Fluorescent Sensors for Measuring Metal Ions in Living Systems
2014 Standout
The Outlook for Survivors of ARDS
1983
Comparing the Means of Several Groups
1985
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
1995 Standout
Pulmonary Function following the Adult Respiratory Distress Syndrome
1978
A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice.
1984
Prediction of pulmonary function abnormalities after adult respiratory distress syndrome (ARDS).
1987
Familial fibrosing alveolitis
1981
Cutaneous leukocytoclastic vasculitis. Clinical and laboratory features of 82 patients seen in private practice
1984
Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome
2000 Standout
Interleukin-13: Central Mediator of Allergic Asthma
1998 StandoutScience
Idiopathic Pulmonary Fibrosis
1976
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival
1980
Cryptogenic fibrosing alveolitis: Assessment by graded trephine lung biopsy histology compared with clinical, radiographic, and physiological features
1981
Circulating immune complexes in patients with cryptogenic fibrosing alveolitis.
1979
The Acute Respiratory Distress Syndrome
1996 Standout
Preservation of Normal Lung Regions in the Adult Respiratory Distress Syndrome
1986
The Biology and Detection of Immune Complexes
1980
Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features
1980
Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy.
1980
A comparison of bronchiolitis obliterans with organizing pneumonia, usual interstitial pneumonia, and small airways disease.
1987
Home environmental intervention benefits urban children with atopic asthma
2004
Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up.
1992
Lung structure and function in cigarette smokers.
1994
Interstitial lung disease: Current concepts of pathogenesis, staging and therapy
1981
Long-term follow-up and bronchial reactivity testing in survivors of the adult respiratory distress syndrome.
1978
Works of Ray E. Stanford being referenced
Bronchoalveolar Lavage Fluid Neutrophils Increase after Corticosteroid Therapy in Smokers with Idiopathic Pulmonary Fibrosis 1– 4
1986
A Clinical, Radiographic, and Physiologic Scoring System for the Longitudinal Assessment of Patients with Idiopathic Pulmonary Fibrosis 1– 3
1986
Small Airway Dimension and Size Distribution in Human Lungs with an Increased Closing Capacity 1- 3
1982
Small Airway Pathology is Related to Increased Closing Capacity and Abnormal Slope of Phase III in Excised Human Lungs 1– 3
1980
Gastrointestinal involvement in leukocytoclastic vasculitis and polyarteritis nodosa.
1981
Prognosis after recovery from adult respiratory distress syndrome.
1976
Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy.
1987
PULMONARY MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS: REVIEW OF TWELVE CASES OF ACUTE LUPUS PNEUMONITIS
1975
Bronchiolitis Obliterans
1983
The morphologic features of the bronchi, bronchioles, and alveoli in chronic airway obstruction: a clinicopathologic study.
1976
Abnormalities in Lung Elastic Properties and Surfactant Function in Adult Respiratory Distress Syndrome
1979
Bronchoalveolar Lavage Fluid Lymphocyte Content Reflects the Histologic Alveolar Wall Inflammation of Idiopathic Pulmonary Fibrosis, Whereas Neutrophil Content Does Not
1986
INTERSTITIAL LUNG DISEASE IN POLYMYOSITIS AND DERMATOMYOSITIS: ANALYSIS OF SIX CASES AND REVIEW OF THE LITERATURE
1976
Circulating Immune Complexes in the Idiopathic Interstitial Pneumonias
1978